复方丹参川芎唪联合多巴胺治疗肺心病疗效观察

摘要

Objective:To observe effect of Compound Danshen Ligustrazin combined Dopamine treatment for pulmonary heart disease.Method:In our hospital 60 patients with pulmonary heart disease from December 2011 to December 2013 were selected as objects,they were randomly divided into observation group and control group,each group contained 30 cases. The control group was given conventional comprehensive therapy,the observation group on the basis of routine comprehensive treatment was given Compound Danshen Ligustrazin combined with dopamine.Clinical treatment effect of the two groups was analyzed.Result:The total efficiency of the control group was 53.3%,there were 14 patients after the treatment invalid,the average time of the patients symptoms full control was(5.7±2.3) days.And the total efficiency of the observation group was 93.3%,invalid after the treatment of 2 patients,patients with symptoms to achieve complete control of average time was (2.4±0.6) days.Clinical therapeutic effect, the average time of complete control of the disease and PaO2,PaCO2levels after treatment in the observation group were significantly better than the control group(P<0.05).Conclusion:Compound Danshen Ligustrazin combined with dopamine for the treatment of pulmonary heart disease,has a better treatment effect,it is worthy to popularize in the clinical application.%目的：对复方丹参川芎唪联合多巴胺进行肺心病治疗的临床疗效进行观察分析。方法：选取本院呼吸内科病室2011年12月-2013年12月收治的60例肺心病患者作为研究对象，将患者按随机数字表法分为观察组与对照组各30例，对照组采用常规的综合治疗方法，观察组在常规综合治疗基础上，给予患者复方丹参川芎唪联合多巴胺治疗，对比分析两组患者的临床疗效。结果：对照组患者的治疗总有效率为53.3%，有14例患者治疗后无效，患者病症实现完全控制的平均时间为（5.7±2.3）d；观察组患者的治疗总有效率为93.3%，2例患者经治疗后无效，患者病症实现完全控制的平均时间为（2.4±0.6）d。观察组患者的临床治疗效果、病症实现完全控制的平均时间及治疗后的PaO2、PaCO2水平均明显优于对照组（P<0.05）。结论：复方丹参川芎唪联合多巴胺进行肺心病治疗，具有相对较好的治疗效果，值得在临床中进行推广应用。